First Test to Detect Zika in Blood Donations Approved

Share this content:
First Test to Detect Zika in Blood Donations Approved
First Test to Detect Zika in Blood Donations Approved

FRIDAY, Oct. 6, 2017 (HealthDay News) -- The cobas Zika test has been approved by the U.S. Food and Drug Administration -- the first approved screening test to detect the Zika virus in blood donations.

The test is not designed to diagnose any particular individual's Zika infection, however, the FDA said.

In August 2016, the agency recommended that all U.S. states and territories screen blood for Zika, according to an FDA media release. "Screening blood donations for the Zika virus is critical to preventing infected donations from entering the U.S. blood supply," said Peter Marks, M.D., Ph.D., director of the FDA's Center for Biologics Evaluation and Research.

Some blood-collection centers had already been using the cobas test in order to comply with the 2016 edict. Data collected from this testing, in tandem with additional information provided by the test's manufacturer, were used to approve the diagnostic, the FDA said. The test has a specificity of more than 99 percent.

The cobas test is produced by Roche Molecular Systems, based in Pleasanton, California.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Doctors Urged to Speak With Patients About Firearms

Doctors Urged to Speak With Patients About Firearms

Making a public commitment is encouraged as a positive action that physicians can take

Machine Learning Model Predicts Risk of Upgrade to Breast CA

Machine Learning Model Predicts Risk of Upgrade to ...

Model can predict risk of upgrade of high-risk breast lesions to cancer using traditional, text features

Glycemic Control Up With Oral Semaglutide in Type 2 Diabetes

Glycemic Control Up With Oral Semaglutide in Type ...

Phase 3 studies next to assess longer-term/clinical outcomes, safety

is free, fast, and customized just for you!

Already a member?

Sign In Now »